Plunkett Research Online: Aptevo Therapeutics

APTEVO THERAPEUTICS (APVO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

A biosciences company.....

Aptevo Therapeutics
Ticker: APVO
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Phone: 206 838-0500
Fax: 206 838-0503
Address: 2401 4th Avenue
Suite 1050
Seattle, WA 98121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
Contacts Description

Jeffrey Lamothe CFO/Chief Accounting Officer/Senior VP
Fuad El-Hibri Chairman of the Board/Director
See More
A biosciences company.....See More See More

Auditor: Moss Adams LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: